SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-035480
Filing Date
2024-09-09
Accepted
2024-09-09 16:30:17
Documents
3
Period of Report
2024-09-09

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 1102684
2 proxycard_001.jpg GRAPHIC 385232
3 proxycard_002.jpg GRAPHIC 299043
  Complete submission text file 0001493152-24-035480.txt   2046325
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41184 | Film No.: 241287605
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)